Clarius Group LLC Takes Position in The Cooper Companies, Inc. (NYSE:COO)

Posted by on Jun 30th, 2023

Clarius Group LLC acquired a new stake in shares of The Cooper Companies, Inc. (NYSE:COO – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 564 shares of the medical device company’s stock, valued at approximately $211,000.

Several other institutional investors have also modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of Cooper Companies by 1.0% during the 3rd quarter. Vanguard Group Inc. now owns 5,486,539 shares of the medical device company’s stock valued at $1,447,898,000 after purchasing an additional 56,846 shares in the last quarter. State Street Corp lifted its stake in Cooper Companies by 0.5% in the 1st quarter. State Street Corp now owns 2,177,872 shares of the medical device company’s stock valued at $909,458,000 after acquiring an additional 10,373 shares in the last quarter. Veritas Asset Management LLP lifted its stake in Cooper Companies by 1.9% in the 4th quarter. Veritas Asset Management LLP now owns 2,091,844 shares of the medical device company’s stock valued at $691,710,000 after acquiring an additional 38,832 shares in the last quarter. Generation Investment Management LLP lifted its stake in Cooper Companies by 30.8% in the 4th quarter. Generation Investment Management LLP now owns 1,639,122 shares of the medical device company’s stock valued at $542,008,000 after acquiring an additional 386,116 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its stake in Cooper Companies by 8.1% in the 3rd quarter. Alliancebernstein L.P. now owns 1,577,676 shares of the medical device company’s stock valued at $416,349,000 after acquiring an additional 118,239 shares in the last quarter. Institutional investors own 98.36% of the company’s stock.

Cooper Companies Stock Down 0.1 %

COO opened at $379.98 on Friday. The Cooper Companies, Inc. has a 1-year low of $244.21 and a 1-year high of $395.20. The stock’s fifty day simple moving average is $374.78 and its 200 day simple moving average is $355.73. The company has a current ratio of 1.69, a quick ratio of 0.95 and a debt-to-equity ratio of 0.35. The stock has a market cap of $18.81 billion, a PE ratio of 65.51, a price-to-earnings-growth ratio of 2.66 and a beta of 0.92.

Cooper Companies (NYSE:COO – Free Report) last posted its quarterly earnings results on Thursday, June 1st. The medical device company reported $3.08 earnings per share for the quarter, beating analysts’ consensus estimates of $3.04 by $0.04. Cooper Companies had a return on equity of 8.18% and a net margin of 8.41%. The business had revenue of $877.40 million for the quarter, compared to analysts’ expectations of $865.81 million. During the same quarter in the prior year, the business earned $3.24 EPS. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. As a group, research analysts expect that The Cooper Companies, Inc. will post 12.79 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Stifel Nicolaus boosted their target price on Cooper Companies from $380.00 to $420.00 in a research note on Tuesday, May 16th. Piper Sandler boosted their target price on Cooper Companies from $375.00 to $430.00 in a research note on Wednesday, May 24th. Robert W. Baird boosted their target price on Cooper Companies from $385.00 to $400.00 in a research note on Friday, June 2nd. TheStreet cut Cooper Companies from a “b-” rating to a “c+” rating in a research note on Friday, June 16th. Finally, Wells Fargo & Company upped their price objective on Cooper Companies from $355.00 to $430.00 in a research note on Monday, May 15th. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average price target of $393.89.

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Read More

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COO – Free Report).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.